---
title: "CROWNICORP offers nearly a 20% discount for a three-for-one share placement, raising up to 620 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267066736.md"
description: "CROWNICORP announced a proposed one-for-three rights issue, issuing up to 953 million shares; the rights issue price is HKD 0.65, a discount of 19.75% compared to the last trading day (21st). The maximum fundraising amount is HKD 620 million, with a net amount of HKD 618 million intended to be fully used for the development of residential land located in the Qianhai New Area of Shenzhen"
datetime: "2025-11-23T10:16:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267066736.md)
  - [en](https://longbridge.com/en/news/267066736.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267066736.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/267066736.md) | [繁體中文](https://longbridge.com/zh-HK/news/267066736.md)


# CROWNICORP offers nearly a 20% discount for a three-for-one share placement, raising up to 620 million

CROWNICORP (00727.HK) announced a proposed rights issue, issuing up to 953 million shares; the rights issue price is HKD 0.65, a discount of 19.75% compared to the last trading day (21st). The maximum fundraising amount is HKD 620 million, with a net amount of HKD 618 million intended to be used entirely for the development of residential land located in the Qianhai New Area of Shenzhen

### Related Stocks

- [CROWNICORP (00727.HK)](https://longbridge.com/en/quote/00727.HK.md)

## Related News & Research

- [Booker on Trump paying TSA: 'Why didn't he do this weeks ago'](https://longbridge.com/en/news/280917023.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [CSC Financial Sticks to Their Buy Rating for Longfor Group Holdings (LNGPF)](https://longbridge.com/en/news/280898279.md)
- [Longfor Group Holdings (LNGPF) Gets a Buy from CICC](https://longbridge.com/en/news/280899756.md)
- [Huatai Securities Keeps Their Buy Rating on C&D International Investment Group Ltd. (1908)](https://longbridge.com/en/news/280868130.md)